Where can PARP inhibitors be used

What are PARP inhibitors and where do we use them in breast cancer?Подробнее

What are PARP inhibitors and where do we use them in breast cancer?

Optimizing PARP Inhibitor Therapies in Veterans With Prostate CancerПодробнее

Optimizing PARP Inhibitor Therapies in Veterans With Prostate Cancer

Advancing Therapeutic Paradigms for Ovarian Cancer in The Era of PARP Inhibitors: A Guide for The...Подробнее

Advancing Therapeutic Paradigms for Ovarian Cancer in The Era of PARP Inhibitors: A Guide for The...

Identifying Mutations and Optimizing Use of PARP InhibitorsПодробнее

Identifying Mutations and Optimizing Use of PARP Inhibitors

Dr Gong on the Frontline Use of PARP Inhibitors in mCRPCПодробнее

Dr Gong on the Frontline Use of PARP Inhibitors in mCRPC

PARP Inhibitors in Ovarian Cancer Treatment: Understanding Side EffectsПодробнее

PARP Inhibitors in Ovarian Cancer Treatment: Understanding Side Effects

The Role of PARP Inhibitors in Advanced Prostate CancerПодробнее

The Role of PARP Inhibitors in Advanced Prostate Cancer

Chemotherapy: PARP-inhibitors, Bevacizumab, and Ovarian CytotoxicsПодробнее

Chemotherapy: PARP-inhibitors, Bevacizumab, and Ovarian Cytotoxics

Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treat...Подробнее

Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treat...

PARP Inhibitors in Prostate Cancer Treatment - Program: Patient Education Ambassadors 2023-24Подробнее

PARP Inhibitors in Prostate Cancer Treatment - Program: Patient Education Ambassadors 2023-24

Cancer Topics - Role of PARP Inhibitors in Prostate CancerПодробнее

Cancer Topics - Role of PARP Inhibitors in Prostate Cancer

M1 CRPC: PARP Inhibitors, Microsatellite Instability  and Precision MedicineПодробнее

M1 CRPC: PARP Inhibitors, Microsatellite Instability  and Precision Medicine

Precision Medicine in Oncology: Ep.11. Selection and use of PARP inhibitors for first-line mainte...Подробнее

Precision Medicine in Oncology: Ep.11. Selection and use of PARP inhibitors for first-line mainte...

PARP Inhibitor Maintenance in Newly Diagnosed Ovarian Cancer: Key Questions, Answers, and Insights Подробнее

PARP Inhibitor Maintenance in Newly Diagnosed Ovarian Cancer: Key Questions, Answers, and Insights 

Assessing Risk of Myelosuppression With PARP Inhibitors in Prostate Cancer With Karan Jatwani, MBBSПодробнее

Assessing Risk of Myelosuppression With PARP Inhibitors in Prostate Cancer With Karan Jatwani, MBBS

Evaluating future use of PARP inhibitors in neoadjuvant therapy for ovarian cancerПодробнее

Evaluating future use of PARP inhibitors in neoadjuvant therapy for ovarian cancer

Global Perspectives on PARP inhibitor Combinations in mCRPC Match Play: European vs. US Integrati...Подробнее

Global Perspectives on PARP inhibitor Combinations in mCRPC Match Play: European vs. US Integrati...

Improving Interprofessional Management and Clinical Outcomes with PARP Inhibitors for Advanced Ov...Подробнее

Improving Interprofessional Management and Clinical Outcomes with PARP Inhibitors for Advanced Ov...

Opportunities and Challenges in Early Breast Cancer: Do PARP Inhibitors Have a Role?Подробнее

Opportunities and Challenges in Early Breast Cancer: Do PARP Inhibitors Have a Role?

PARP Inhibitor Combination Regimens for Prostate Cancer ManagementПодробнее

PARP Inhibitor Combination Regimens for Prostate Cancer Management